Contributing an Abstract
to CASD 2015
Abstracts may be submitted for consideration in a
contributed/technical or clinical session. Descriptions of both session types
are given below. To
submit a paper for consideration, please send the following information by
September 4 to Martinez.Wendy@bls.gov.
1.
Title of paper and a brief abstract
2.
Name of author(s) and exact title of the organization(s).
3.
Type of paper (technical or clinical).
4.
Telephone number of the author(s).
5.
E-mail address of the author(s).
Speakers
will be notified regarding paper acceptance on a rolling basis, but no later
than September 12.
Technical Papers
Contributed/technical
papers can vary in content from new research to well-posed problems in which
statistical methods are applied to solve specific defense problems. Speakers
are strongly encouraged to present their papers in terms of the potential or
real problems that motivated the work. Where the solution to a problem relies
on relatively recent or specialized results in the theory of statistics and
probability, these results should be explained or documented in sufficient
detail to permit an audience of statistical practitioners with broadly varying
backgrounds to utilize the results to enhance their problem solving
capabilities.
Clinical Papers
A
distinct feature of this conference is the Clinical Session. Presentations
feature applied statistics problems which have not been completely or
satisfactorily solved, and for which the presenter seeks assistance in
developing a satisfactory approach. A panel of experts, composed of invited
speakers and other distinguished attendees, convenes for each clinical session
to provide guidance. Authors of a clinical paper must provide a description of
the problem by September 19 so that the panelists have sufficient time to
prepare their recommendations. We invite you to consider this opportunity to present
an interesting statistical problem to some of the country's leading applied and
mathematical statisticians.
Presentation Time
Technical
papers are nominally allowed 30 minutes, to include 5 minutes at the end for
audience discussion and questions. Of the 40 minutes available for clinical
papers, approximately 15 minutes are recommended for the problem statement,
allowing 25 minutes for panel discussion. Invited presentations are 45 minutes.